Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer.
about
Certainty of S100 from Physiology to PathologyAnalysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research.Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications.Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation.Detection of bladder cancer using proteomic profiling of urine sedimentsClassification of premalignant pancreatic cancer mass-spectrometry data using decision tree ensembles.Clinical implications and utility of field cancerizationA mixture model approach to the tests of concordance and discordance between two large-scale experiments with two-sample groups.Applications of SELDI-MS technology in oncologyProteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.Plasma protein profiles differ between women diagnosed with cervical intraepithelial neoplasia (cin) 1 and 3.Analysis of blood stem cell activity and cystatin gene expression in a mouse model presenting a chromosomal deletion encompassing Csta and Stfa2l1Advances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer.Mass spectrometry protein expression profiles in colorectal cancer tissue associated with clinico-pathological features of disease.Reference spectra from squamous epithelium and connective tissue allow whole section proteomics analysis.Analysis of differentially expressed proteins in oral squamous cell carcinoma by MALDI-TOF MS.[Translational research in head and neck cancer. Biological characteristics and general aspects].Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samplesLaser ionization mass spectrometry in oral squamous cell carcinoma.Tumoral heterogeneity of hepatic cholangiocarcinomas revealed by MALDI imaging mass spectrometry.Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.Anticancer activity of pyrithione zinc in oral cancer cells identified in small molecule screens and xenograft model: Implications for oral cancer therapy.Meta-Analyses of Microarray Datasets Identifies ANO1 and FADD as Prognostic Markers of Head and Neck CancerMALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis.Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometryA Cancer-Indicative microRNA Pattern in Normal Prostate Tissue.CD8+ T-cell responses against hemoglobin-beta prevent solid tumor growth.Molecular techniques and genetic alterations in head and neck cancer.Dysregulated molecular networks in head and neck carcinogenesisNext-generation technologies for spatial proteomics: Integrating ultra-high speed MALDI-TOF and high mass resolution MALDI FTICR imaging mass spectrometry for protein analysis.Background coloration of squamous epithelium in esophago-pharyngeal squamous cell carcinoma: what causes the color change?Identification of human tissue kallikrein 6 as a potential marker of laryngeal cancer based on the relevant secretory/releasing protein database.An overview of the molecular pathology of head and neck cancer, and its clinical implications.Genomic sequencing and precision medicine in head and neck cancers.Murine cutaneous leishmaniasis investigated by MALDI mass spectrometry imaging.Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers.Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck.Implication for second primary cancer from visible oral and oropharyngeal premalignant lesions in betel-nut chewing related oral cancer.Human β-defensins and psoriasin/S100A7 expression in salivary glands: anti-oncogenic molecules for potential therapeutic approaches.
P2860
Q26738389-DC48B6E3-9740-4469-A940-2AFD1688D2BFQ28396816-8D59AF28-1E0A-4AB3-A6A4-171639643C24Q30248577-2124D750-5B71-4749-A6EA-F7B9883EBCFBQ30477571-1A344129-0FD7-4D81-A31B-A172AE7E7CEBQ31083527-2295E9B0-073B-41BE-85D6-A27733399C19Q31158913-8F2DB7BB-3AA8-4ABB-A682-605BB285A94BQ33278836-E033F61F-83B6-45C7-A8A9-5526AD0763B2Q33279912-B58C80FD-FB72-4A77-B074-20DDFC32D1D6Q33319301-73B327DF-57AE-40A5-A714-419A12ABDB18Q33365079-B9CAD98E-DD25-49D1-BF50-F38DF38C3BC8Q33449337-6F39E167-8B24-4F06-8FCA-91ED6760C430Q33511237-3622108E-BE0C-46C3-95D6-98C3006E00D8Q33610394-2D366F8F-B948-4406-B697-2DDE685E6F97Q33651645-255D8F54-24EC-4E6D-960D-E60547B06146Q33748119-7AABBF0C-CF08-448A-9322-911436528BC6Q33774554-F707A84B-443C-4F17-B732-6938A1CE8079Q34000961-ABD10A76-DBE9-4FA3-A756-3821F19BD730Q34760619-CC3CA21A-E45B-493E-999D-EA93954D5878Q35013394-0E97717F-0915-42B3-9BA6-DACDB72DD198Q35134122-191D34FC-D27E-405F-AFA6-E5132B290D01Q35673572-1826C19F-B7C9-45BF-AD1C-F7792E7170E6Q35675984-4DB4DDA4-2EC0-43E6-962F-FF2DDC43321AQ35903521-897225A1-E4D6-45C1-87F9-956692366B49Q36100349-EF693B95-9C3B-410A-A7CA-E4E41A689E7DQ36713650-0C87DF8B-1E15-4FAD-BFB4-108463ECC80CQ36790412-539D7E2D-73D8-40A9-BE93-C322C086B954Q37003256-3ECB1A1D-EE6C-486C-82BB-B28BE6138481Q37233399-E12B9D7F-CD8F-4D02-B89A-618661FAF2C4Q37274623-BDDC1CF4-B64A-4E7B-8A38-9F3D29108D1FQ37426939-4BD32EB6-0812-4207-B46D-415DFA71C47AQ37525155-6B8B9930-97DF-4F3F-8272-B4DEB41AA941Q37616960-B1409BCC-F523-4C0B-96B6-E85962AB6534Q37903910-F42F2675-A661-46AB-860E-A3BA0B179586Q38776454-6FB06A90-7ED4-4D12-9369-3B01FC0E03BEQ39298243-BDA55014-F0AB-4382-81C2-DCDF20A21DDEQ39539278-DB913B20-5D1B-4E48-8C6B-D230E60E09C1Q47139532-0467532B-BE52-4DA8-8868-D5DD45DF86ABQ50928111-34A5CEB5-BAF6-4C4A-B440-EAB6C36DA8A2Q54335180-987F8391-57C0-46F8-81EB-518E7E89CAB1
P2860
Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Proteomic analysis reveals suc ...... invasive head and neck cancer.
@ast
Proteomic analysis reveals suc ...... invasive head and neck cancer.
@en
type
label
Proteomic analysis reveals suc ...... invasive head and neck cancer.
@ast
Proteomic analysis reveals suc ...... invasive head and neck cancer.
@en
prefLabel
Proteomic analysis reveals suc ...... invasive head and neck cancer.
@ast
Proteomic analysis reveals suc ...... invasive head and neck cancer.
@en
P2093
P356
P1433
P1476
Proteomic analysis reveals suc ...... invasive head and neck cancer
@en
P2093
Plinkert PK
Roesch-Ely M
Schnölzer M
P2888
P356
10.1038/SJ.ONC.1209770
P407
P577
2006-07-03T00:00:00Z
P5875
P6179
1048536955